Massachusetts Financial Services Co. MA Has $39.68 Million Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Massachusetts Financial Services Co. MA grew its position in HealthEquity, Inc. (NASDAQ:HQY) by 7.4% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 484,782 shares of the company’s stock after purchasing an additional 33,523 shares during the period. Massachusetts Financial Services Co. MA’s holdings in HealthEquity were worth $39,679,000 at the end of the most recent quarter.

Several other institutional investors have also made changes to their positions in HQY. Clearbridge Investments LLC boosted its stake in HealthEquity by 1.9% in the 2nd quarter. Clearbridge Investments LLC now owns 2,377,204 shares of the company’s stock worth $204,915,000 after purchasing an additional 43,491 shares during the period. Mackenzie Financial Corp grew its holdings in shares of HealthEquity by 16.0% during the second quarter. Mackenzie Financial Corp now owns 2,364,521 shares of the company’s stock valued at $203,822,000 after buying an additional 325,906 shares in the last quarter. Dimensional Fund Advisors LP raised its position in HealthEquity by 8.1% during the second quarter. Dimensional Fund Advisors LP now owns 1,547,402 shares of the company’s stock valued at $133,377,000 after buying an additional 115,841 shares during the period. Allspring Global Investments Holdings LLC lifted its stake in HealthEquity by 0.8% in the 2nd quarter. Allspring Global Investments Holdings LLC now owns 1,122,057 shares of the company’s stock worth $96,721,000 after acquiring an additional 9,125 shares in the last quarter. Finally, Janus Henderson Group PLC boosted its position in HealthEquity by 1.1% during the 1st quarter. Janus Henderson Group PLC now owns 1,100,715 shares of the company’s stock worth $89,851,000 after acquiring an additional 12,448 shares during the period. 99.55% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, Director Frank Corvino sold 1,247 shares of the company’s stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $80.26, for a total transaction of $100,084.22. Following the completion of the transaction, the director now directly owns 4,823 shares in the company, valued at $387,093.98. This represents a 20.54 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Robert W. Selander sold 8,250 shares of the firm’s stock in a transaction on Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total transaction of $684,585.00. Following the completion of the sale, the director now owns 54,719 shares in the company, valued at $4,540,582.62. This represents a 13.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 10,536 shares of company stock valued at $884,517. 2.20% of the stock is owned by insiders.

Wall Street Analyst Weigh In

HQY has been the topic of a number of research reports. JMP Securities reiterated a “market outperform” rating and issued a $105.00 target price on shares of HealthEquity in a report on Wednesday, September 4th. Deutsche Bank Aktiengesellschaft lifted their target price on shares of HealthEquity from $102.00 to $103.00 and gave the company a “buy” rating in a research note on Wednesday, September 4th. Royal Bank of Canada reiterated an “outperform” rating and set a $92.00 price objective on shares of HealthEquity in a report on Wednesday, September 4th. Barrington Research restated an “outperform” rating and issued a $105.00 target price on shares of HealthEquity in a research note on Friday, September 20th. Finally, BTIG Research raised their price target on HealthEquity from $110.00 to $130.00 and gave the stock a “buy” rating in a research note on Thursday, November 14th. One analyst has rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $107.23.

HealthEquity Stock Down 0.4 %

Shares of HQY stock opened at $104.25 on Monday. The stock’s 50 day simple moving average is $87.74 and its 200 day simple moving average is $81.95. HealthEquity, Inc. has a twelve month low of $62.10 and a twelve month high of $105.73. The company has a debt-to-equity ratio of 0.51, a quick ratio of 4.10 and a current ratio of 4.10. The company has a market capitalization of $9.10 billion, a price-to-earnings ratio of 86.88, a PEG ratio of 1.64 and a beta of 0.52.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings data on Tuesday, September 3rd. The company reported $0.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.50 by $0.16. The business had revenue of $299.93 million during the quarter, compared to the consensus estimate of $284.48 million. HealthEquity had a net margin of 9.61% and a return on equity of 9.01%. As a group, research analysts predict that HealthEquity, Inc. will post 2.27 EPS for the current year.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.